Natera director Chapman Rowan E sells $300k in inventory

Chapman Rowan E, a director at Natera, Inc. (NASDAQ:NTRA), has bought 1,767 shares of the corporate’s widespread inventory. The shares had been bought at a weighted common worth of $170.24, with particular person transaction costs starting from $170.22 to $170.32. This sale, accomplished on December 10, 2024, amounted to a complete worth of roughly $300,808. The transaction happens as Natera trades close to its 52-week excessive of $175.63, having surged 185% over the previous yr and 48% within the final six months. Following this transaction, Rowan E holds 6,202 shares of Natera instantly. In response to InvestingPro evaluation, the inventory at the moment seems overvalued, with 14 extra unique insights obtainable to subscribers by the excellent Professional Analysis Report.

In different latest information, Natera Inc (NASDAQ:NTRA). has reported vital developments. The corporate lately amended its settlement with Government Chairman Dr. Rabinowitz, who will proceed his position on an at-will foundation, with an annual base wage set at half of the CEO’s base wage. Moreover, Natera confronted a setback in a false promoting lawsuit towards Guardant Well being (NASDAQ:GH), however stays agency in its disagreement with the choice. Regardless of this, Natera reported a document Q3 income of $439.8 million, a 64% enhance year-over-year, and carried out 137,000 oncology assessments, marking a 54% enhance from the earlier yr. The corporate’s gross margins reached a document excessive of 62%, resulting in a revision of its full-year income steering to between $1.61 billion and $1.64 billion. Analyst companies TD Cowen, Baird, and Jefferies have maintained favorable scores on Natera’s inventory and raised their worth targets. These are latest developments which have emerged from the corporate’s operations.

This text was generated with the help of AI and reviewed by an editor. For extra data see our T&C.